Daily non-political popular news in brief.

Study urges compensation-based approach to drug patent compulsory licensing

A Penn State researcher argues that ambiguous international rules outlining when and how governments may "break" pharmaceutical patents may end up significantly reducing incentives for innovation while at the same time failing to increase access to medicines.

Read more »

Keywords: study, urges, compensation-based, approach, drug, patent, compulsory, licensing, urge, compensation, based

« Previous | Next »

Similar news on "Study urges compensation-based approach to drug patent compulsory licensing":

1. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
2. New nanotoxicology study delivers promising results
   08-17-2007 · Oak Ridge National Laboratory (ORNL)
   Findings by a team of researchers from Oak Ridge National Laboratory and the University of Tennessee bode well for using single-walled carbon nanohorns, a particular form of engineered carbon-based nanoparticles, for drug delivery and other commercial applications.
   Similar news · Read more »
   
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
   08-15-2007 · UT Southwestern Medical Center
   A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.
   Similar news · Read more »
   
4. Doctors Develop New Approach To Web-based Drug Withdrawal Warnings
   10-02-2006 · ScienceDaily
   The University of Cincinnati has developed a faster approach for informing consumers online when the Food and Drug Administration (FDA) withdraws a medication. Researchers hope this new 24-hour update method will become the standard response system for Web sites carrying critical consumer health information.
   Similar news · Read more »
   
5. New Materials for Making "Spintronic" Devices
   04-25-2007 · Brookhaven National Laboratory
   An interdisciplinary group of scientists at Brookhaven has devised methods to make a new class of electronic devices based on a property of electrons known as "spin," rather than merely their electric charge. This approach, dubbed spintronics, could open the way to increasing dramatically the productivity of electronic devices operating at the nanoscale - on the order of billionths of a meter. The Brookhaven scientists have filed a U.S. provisional patent application for their invention, which i
   Similar news · Read more »
   
6. Commentary highlights impact of food-cancer drug interactions
   07-17-2007 · EurekAlert!
   A commentary in the Journal of Clinical Oncology, urges researchers to explore an intriguing approach to reduce the dose and therefore the cost, of oral targeted cancer therapies.
   Similar news · Read more »
   
7. Mayo Clinic study indicates medication for ADHD may help student outcomes
   09-18-2007 · EurekAlert!
   In an 18-year-study on attention-deficit/hyperactivity disorder, Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD. The Mayo Clinic results are the first population-based data to show stimulant drug therapy helps improve long-term school outcomes.
   Similar news · Read more »
   
8. Return on investment for pediatric exclusivity program varies widely for pharmaceutical companies
   02-06-2007 · EurekAlert!
   The economic return for a program designed to encourage drug manufacturers to conduct more pediatric clinical trials by granting extensions of patent protection or marketing exclusivity generates lucrative returns for blockbuster products and produces more modest returns on investment for many others, according to a study in the Feb. 7 issue of JAMA.
   Similar news · Read more »
   
9. UCLA imaging study reveals how pure oxygen harms the brain
   05-21-2007 · EurekAlert!
   A new UCLA imaging study reveals how inhaling 100 percent oxygen can harm the brain. The findings fly in the face of national guidelines for resuscitation and urge a new approach adding carbon dioxide to the gas mix to preserve brain function in patients.
   Similar news · Read more »
   
10. NIDA study identifies genes that might help some people abstain from smoking
    04-02-2007 · EurekAlert!
    NIDA-supported research has for the first time identified genes that might increase a person's ability to abstain from smoking. The research brings researchers a step closer toward tailoring drug therapy for addiction based on an individual's unique genetic makeup.
    Similar news · Read more »